Tectonic Therapeutic TECX
NASDAQ TECX
$23.29 -0.05 (-0.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

Tectonic Therapeutic (TECX) Cash from Financing Activities (2017 - 2026)

Updated

Tectonic Therapeutic (TECX) reported Cash from Financing Activities of $11.68 million for Q2 2026, compared with -$4.17 million a year earlier.

Analysis

Tectonic Therapeutic (TECX) Cash from Financing Activities (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Tectonic Therapeutic's Cash from Financing Activities came in at $11.93 million, down 92.8% year-over-year; for FY2025, it was $173.36 million, up 1.0% from FY2024.

  • Cash from Financing Activities has a five-year compound annual growth rate of 0.1% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $171.71 million in FY2024 (+408.8%), $33.75 million in FY2023, $262,000 in FY2022 (-99.1%) and $30.37 million in FY2021 (-82.4%).
  • The Q2 2026 figure ranks as the highest quarterly Cash from Financing Activities since Q1 2025.
  • The high point for year-over-year Cash from Financing Activities in five years was Q3 2022 (growth of 172.7%); the low point was Q2 2022 (a decline of 100.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $847,000 (Q1 2026), -$141,000 (Q4 2025) and -$457,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Tectonic Therapeutic 447.99 Mn 447.99 Mn - 11.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.68 Mn
Mar 31, 2026 847,000.00
Dec 31, 2025 -141,000.00
Sep 30, 2025 -457,000.00
Jun 30, 2025 -4.17 Mn
Mar 31, 2025 178.12 Mn
Dec 31, 2024 -1.07 Mn
Sep 30, 2024 -6.29 Mn
Jun 30, 2024 179.74 Mn
Mar 31, 2024 -668,000.00
Dec 31, 2023 34.13 Mn
Sep 30, 2023 -114,000.00
Jun 30, 2023 -324,000.00
Mar 31, 2023 55,000.00
Dec 31, 2022 59,000.00
Sep 30, 2022 60,000.00
Jun 30, 2022 1,000.00
Mar 31, 2022 142,000.00
Dec 31, 2021 14.95 Mn
Sep 30, 2021 22,000.00
API Access

Tectonic Therapeutic Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TECX&period=max&api_key=YOUR_API_KEY